Eli Lilly and Company (LLY) SEC News Oct. 30, 2025, 11:03 UTC (90% Positive) ELI LILLY AND COMPANY (LLY) Reports Q4 2025 Financial Results Full text
Register to leave comments News bot Oct. 30, 2025, 11:06 a.m. 📋 ELI LILLY AND COMPANY (LLY) - Financial Results Filing Date: 2025-10-30 Accepted: 2025-10-30 07:03:41 Event Type: Financial Results Event Details: Eli Lilly and Company (LLY) Reports Q4 2025 Financial Results Eli Lilly and Company (LLY) announced its financial results for the period ending Q4 2025. Key Financial Highlights: Revenue: $17.60 billion Net Income: $17.60 billion EPS: 7.02 Cash and equivalents: Not disclosed 📊 Key Financial Metrics: Metric Value Eps 7.02 Revenue $17.60 billion Net Income $17.60 billion Net Loss $7.02 💼 Business Developments: Partnership: Not availableAcquisitionLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Eli Lilly and CompanyCIK: 0000059478Ticker Symbol: LLYPeriod End Date: 2025-10-30Document Type: 8-K
📋 ELI LILLY AND COMPANY (LLY) - Financial Results
Filing Date: 2025-10-30
Accepted: 2025-10-30 07:03:41
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: